GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Median PS Value

Carna Biosciences (TSE:4572) Median PS Value : 円1,197.33 (As of May. 23, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Carna Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円92.177. Carna Biosciences's 10-Year median PS Ratio is 12.9895. Therefore, the Median PS Value for today is 円1,197.33.

As of today (2024-05-23), Carna Biosciences's share price is 円396.00. Carna Biosciences's Median PS Value is 円1,197.33. Therefore, Carna Biosciences's Price to Median PS Value for today is 0.33.

The historical rank and industry rank for Carna Biosciences's Median PS Value or its related term are showing as below:

TSE:4572' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.33   Med: 0.69   Max: 1.42
Current: 0.33

During the past 13 years, the highest Price to Median PS Value of Carna Biosciences was 1.42. The lowest was 0.33. And the median was 0.69.

TSE:4572's Price-to-Median-PS-Value is ranked better than
78.93% of 261 companies
in the Biotechnology industry
Industry Median: 0.68 vs TSE:4572: 0.33

Carna Biosciences Median PS Value Historical Data

The historical data trend for Carna Biosciences's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Median PS Value Chart

Carna Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,994.15 1,035.37 2,034.08 1,336.89 1,247.15

Carna Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 970.44 900.81 817.30 1,247.15 1,197.33

Competitive Comparison of Carna Biosciences's Median PS Value

For the Biotechnology subindustry, Carna Biosciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carna Biosciences's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's Price-to-Median-PS-Value falls into.



Carna Biosciences Median PS Value Calculation

Carna Biosciences's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=92.177*12.9895
=1,197.33

10-Year Median PS Ratio is 12.9895.
Carna Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円92.177.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carna Biosciences  (TSE:4572) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Carna Biosciences's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=396.00/1,197.33
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carna Biosciences Median PS Value Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Carna Biosciences (TSE:4572) Business Description

Traded in Other Exchanges
N/A
Address
BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines